Introduction: Many neuropeptides have recently been identified in human and animal airways. These peptides have potent effects on airway caliber, blood vessels, and secretions, raising the possibility that they may be involved in airway diseases such as asthma. Objectives of the study: The basic aim of the study is to analyze the use of neuropeptides in asthma and chronic obstructive pulmonary disease in Pakistan. Methodology of the study: This study was conducted at Children Hospital & Institute of Child Health, Multan during January 2018 to April 2018. This study was conducted with the permission of ethical committee of hospital. In this study we analyze the use of different neuropeptide drugs for asthma and chronic obstructive pulmonary ...
Introduction: Inhaled corticosteroids (ICS) are widely used in high doses in the management of obstr...
Introduction: The complexity and heterogeneous nature of asthma and chronic obstructive pulmonary di...
Professor David de Wied first introduced the term 'neuropeptides' at the end of 1971. Later peptide ...
Introduction: Many neuropeptides have recently been identified in human and animal airways. These pe...
Introduction: Lung diseases are among the top 5 mortality-causing diseases in the World. As with man...
Introduction: Lung diseases are among the top 5 mortality-causing diseases in the World. As with man...
Introduction: Bronchial asthma and COPD (Chronic Obstructive Pulmonary Disease) are obstructive pulm...
Asthma and chronic obstructive pulmonary disease (COPD) remain major clinical problems with signific...
In the last decade, the attention of scientists in the field of biomedicine is focused on studying t...
The tachykinin family of peptides are distributed throughout the nervous system and are thought to p...
Asthma and chronic obstructive pulmonary disease (COPD) are major causes of mortality and morbidity...
Introduction: In recent times, the incidence of allergic diseases, particularly bronchial asthma, ha...
Despite recent advances in the development of anti-asthmatic medication, asthma continues to be a ma...
Research Doctorate - Doctor of Philosophy (PhD)Respiratory diseases such as asthma, chronic obstruct...
Bibliography: leaves 217-244.x, 246 leaves : ill. (chiefly col.) ; 30 cm.Tachykinins are implicated ...
Introduction: Inhaled corticosteroids (ICS) are widely used in high doses in the management of obstr...
Introduction: The complexity and heterogeneous nature of asthma and chronic obstructive pulmonary di...
Professor David de Wied first introduced the term 'neuropeptides' at the end of 1971. Later peptide ...
Introduction: Many neuropeptides have recently been identified in human and animal airways. These pe...
Introduction: Lung diseases are among the top 5 mortality-causing diseases in the World. As with man...
Introduction: Lung diseases are among the top 5 mortality-causing diseases in the World. As with man...
Introduction: Bronchial asthma and COPD (Chronic Obstructive Pulmonary Disease) are obstructive pulm...
Asthma and chronic obstructive pulmonary disease (COPD) remain major clinical problems with signific...
In the last decade, the attention of scientists in the field of biomedicine is focused on studying t...
The tachykinin family of peptides are distributed throughout the nervous system and are thought to p...
Asthma and chronic obstructive pulmonary disease (COPD) are major causes of mortality and morbidity...
Introduction: In recent times, the incidence of allergic diseases, particularly bronchial asthma, ha...
Despite recent advances in the development of anti-asthmatic medication, asthma continues to be a ma...
Research Doctorate - Doctor of Philosophy (PhD)Respiratory diseases such as asthma, chronic obstruct...
Bibliography: leaves 217-244.x, 246 leaves : ill. (chiefly col.) ; 30 cm.Tachykinins are implicated ...
Introduction: Inhaled corticosteroids (ICS) are widely used in high doses in the management of obstr...
Introduction: The complexity and heterogeneous nature of asthma and chronic obstructive pulmonary di...
Professor David de Wied first introduced the term 'neuropeptides' at the end of 1971. Later peptide ...